Recruiting NCT07295782
The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: determination of fibrin clot properties.
- Who it may be relevant to
- Registry conditions: Uterine Prolapse, Urine Incontinence. Basic parameters: 18 years — 70 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Poland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Fibrin Clot Properties and Thrombin Generation in Women After Urogynecological Surgery.
Overview
Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.
Detailed description
Fibrin clot permeability and susceptibility to lysis along with thrombin generation
Interventions
- Diagnostic test determination of fibrin clot properties
Determination of fibre clot properties and thrombin generation in women with uterine prolapse/ urine incontinence before and after urogynecological surgery.
Primary outcome measures
- fibrin clot phenotype [Time frame: December 2025 till May 2026]
- Thrombin generation [Time frame: December 2025 till May 2026]
Eligibility criteria
Inclusion criteria
- Age 18-70
- treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence
Exclusion criteria
- prolonged thromboprophylaxis
- planned surgery other than due to urine incontinence/uterine prolapse
- acquired or congenital thrombophilia
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Poland · 1 center
- Gynecological Endocrinology Department — Krakow
Identifiers
NCT: NCT07295782 · 1072.6120.315.2022